ReviewFrontiers in oncology2022

Glypican-3: A Novel and Promising Target for the Treatment of Hepatocellular Carcinoma.

Xiufeng Zheng et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.